Vaccines and Therapeutics Silica nanoparticles to improve the delivery of vaccines and therapeutics Read more History Established in 2014 and listed on the AIM market of the London Stock Exchange in May 2017 Read more Pipeline Near term focus of the Company is on the following products/opportunities. Nuvec Single dose Hepatitis B Read more about our full Pipeline
